Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Coronavirus Notebook: EMA Begins Assessing AZ’s Evusheld, Apeiron Starts Phase I Trial Of Inhaled APN01

Oct 14 2021

• By Ian Schofield

Inhaler — Apeiron Biologics is trialing an inhaled product for COVID-19 • Source: Shutterstock

Related Content

EMA 'Confident' Of New COVID-19 Vaccine Approvals By Year End

Sep 09 2021

Coronavirus Notebook: CEPI Calls For Reduced-Dose Booster Trials, Regeneron’s Ronapreve Filed In EU

Oct 12 2021

Related Companies

AstraZeneca PLC

Regeneron Pharmaceuticals, Inc.

Roche Holding AG

Apeiron Biologics AG

Pfizer Inc.

BioNTech SE

Moderna, Inc.

Novavax, Inc.

Bharat Biotech

Sinopharm Group Co. Ltd.

Additional Topics

Europe United Kingdom Clinical Trials Coronavirus COVID-19 Review Pathway Regulation Vaccines Infectious Diseases BioPharmaceutical

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.